Enhanced Tumor-Targeted Delivery of Arginine-Rich Peptides via a Positive Feedback Loop Orchestrated by

Minghai Ma1, Xing Li2, Minxuan Jing1

  • 1Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.

Insights

Hendeca-arginine peptides (R11) target bladder cancer by engaging the Piezo1/integrin β1 axis. This interaction enhances cellular uptake and prevents lysosomal degradation, improving peptide drug delivery for cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Peptide-based drugs offer promise for cancer treatment but their precise targeting mechanisms remain unclear.
  • Lysosomal entrapment can limit the efficacy of peptide therapeutics.
  • Understanding these mechanisms is crucial for designing effective peptide-drug conjugates.

Purpose of the Study:

  • To synthesize hendeca-arginine peptides (R11) for targeted delivery in bladder carcinoma (BC).
  • To investigate the targeting efficiency and elucidate the mechanism of R11 peptide delivery.
  • To refine the design and efficacy of peptide-based therapeutics.

Main Methods:

  • Synthesis of hendeca-arginine peptides (R11).
  • Investigation of R11 peptide targeting in bladder carcinoma models.
  • Elucidation of the Piezo1/integrin β1 signaling pathway's role in R11 uptake.
  • Analysis of R11 peptide interactions with integrin β1 and lysosomal pathways.

Main Results:

  • The Piezo1/integrin β1 signaling axis significantly facilitates R11 peptide tumor targeting via macropinocytosis.
  • R11 peptides form hydrogen bonds with integrin β1, enhancing tumor cell targeting and penetration.
  • R11 peptides protect integrin β1 from lysosomal degradation, promoting its recycling.
  • A positive feedback loop involving R11, Piezo1, and integrin β1 enhances cellular uptake and transport.

Conclusions:

  • The Piezo1/integrin β1 axis is a key mediator of R11 peptide tumor-targeted delivery.
  • R11 peptides promote their own uptake and transport through a positive feedback mechanism.
  • These findings offer new strategies for modifying peptide drugs to enhance cancer therapy efficacy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K